Shalin Kothari (@kotharishalin) 's Twitter Profile
Shalin Kothari

@kotharishalin

Husband, Father, Son, Brother, Friend and Assistant Professor @YaleMed with a focus on Lymphoid Malignancies. BlueSky: @kotharishalin.bsky.social

ID: 28553937

linkhttps://medicine.yale.edu/profile/shalin_kothari/ calendar_today03-04-2009 12:42:33

517 Tweet

456 Followers

581 Following

uché blackstock, md (@uche_blackstock) 's Twitter Profile Photo

Even brighter news! Dr. Marcella Nunez-Smith, associate professor and founding director of the Equity Research and Innovation Center at Yale School of Medicine, will be one of three co-chairs of Biden’s coronavirus task force! (H/t @Wizdomisms) nhregister.com/news/article/R…

Dr. Deepti Gurdasani (@dgurdasani1) 's Twitter Profile Photo

The Imperial report on the new UK B117 strain is out. Very concerning findings, that highlight why we need to act on this *now*. These findings suggest that the situation within the UK is likely to get much worse than it is now. Here's why- Thread.

Amer Zeidan MBBS,MHS ‏عامر زيدان (@dr_amerzeidan) 's Twitter Profile Photo

Excellent Yale Cancer Center Yale University #ASH20 highlights on lymphoid malignancies by Shalin Kothari Tarsheen Sethi, MD, MSCI Fransceca Montari & moderator Scott Huntington. If you missed you can view recording and slides next week on our website for free and claim the CME credit & check next sessions

Excellent <a href="/YaleCancer/">Yale Cancer Center</a> <a href="/Yale/">Yale University</a> #ASH20 highlights on lymphoid malignancies by <a href="/kotharishalin/">Shalin Kothari</a> <a href="/tarsheen2/">Tarsheen Sethi, MD, MSCI</a> Fransceca Montari &amp; moderator Scott Huntington. If you missed you can view recording and slides next week on our website for free and claim the CME credit &amp; check next sessions
Vinay Prasad MD MPH (@vprasadmdmph) 's Twitter Profile Photo

What we will likely regret re US pandemic: [THREAD] 1. Entire USA shut down hard in early March (for many places this was excessive, 4 others came too late, NYC). Use of restrictions at wrong time depletes the populations energy & cannot be sustained....

Yale Cancer Center (@yalecancer) 's Twitter Profile Photo

Yale Cancer Center is pleased to announce further investment in our Hematology/Oncology Fellowship Program led by Dr. Alfred Lee with a $1.5 million commitment to the program. Yale Hematology Oncology Fellows Yale School of Medicine Yale New Haven Hosp Learn more: bit.ly/352Emq5

Yale Cancer Center is pleased to announce further investment in our Hematology/Oncology Fellowship Program led by Dr. Alfred Lee with a $1.5 million commitment to the program. <a href="/YaleHemOnc/">Yale Hematology Oncology Fellows</a> <a href="/YaleMed/">Yale School of Medicine</a> <a href="/YNHH/">Yale New Haven Hosp</a> 
Learn more: bit.ly/352Emq5
Sam Yamshon (@samyamshon) 's Twitter Profile Photo

There is quite literally no better feeling in the world than showing a patient a PET scan that shows a complete remission. Several in one day is an embarrassment of riches. Feeling grateful, and hoping for many more!

Leo Meriranta (@merijellona) 's Twitter Profile Photo

Friends! I am super-excited to share our story on KLHL6 in this @BCD_aacr 📣KLHL6 targets the B-cell receptor and lymphoma mutations perturb this homeostasis! 🔓Read doi.org/10.1158/2643-3… 🪩Joint editorial in Cancer Discovery doi.org/10.1158/2159-8… 🧵Let’s go

Friends! I am super-excited to share our story on KLHL6 in this @BCD_aacr

📣KLHL6 targets the B-cell receptor and lymphoma mutations perturb this homeostasis!

🔓Read
doi.org/10.1158/2643-3…

🪩Joint editorial in <a href="/CD_AACR/">Cancer Discovery</a> 
doi.org/10.1158/2159-8…

🧵Let’s go
Shalin Kothari (@kotharishalin) 's Twitter Profile Photo

Every so often, you meet patients who, despite their suffering, brighten your perspective with meaningful, selfless lives full of volunteerism. This irreplaceable aspect—the honor of knowing them—will never be threatened by the AI-ification of medicine. This is the art of

Shalin Kothari (@kotharishalin) 's Twitter Profile Photo

The anxiety of navigating trial eligibility criteria to find 'gotcha' exclusions for patients who could benefit is real. Just had to exclude a patient due to a highly curable cancer from almost 2 years ago. Clinical trials (except for FiH studies) MUST evolve to reflect